Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2

Abstract

Our preliminary data suggested that a single dose of BBV152-induced humoral immunity in previously infected individuals was equivalent to two doses of the vaccine in infection-naïve individuals. However, these findings need to be confirmed with large sized cohort studies.